An Overview on Probiotics as an Alternative Strategy for Prevention and Treatment of Human Diseases

被引:10
作者
Taherian, Mahdi [1 ,2 ]
Samadi, Pariya Mahin [3 ]
Rastegar, Hossein [4 ]
Faramarzi, Mohammad Ali [5 ,6 ]
Rostami-Nejad, Mohammad [7 ]
Yazdi, Mohammad Hossein [3 ,8 ,9 ]
Rezaei-Tayirani, Mostafa [10 ]
Yazdi, Zeinab [11 ]
机构
[1] Minist Hlth & Med Educ MOH, Iran Food & Drug Org FDO, Food & Drug Lab Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Dept Med Genet, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Biotechnol Res Ctr, Fac Pharm, Tehran, Iran
[4] Minist Hlth & Med Educ MOH, Food & Drug Cosmet Res Ctr, Iran Food & Drug Org FDO, Tehran, Iran
[5] Univ Tehran Med Sci, Fac Pharm, Dept Pharmaceut Biotechnol, Tehran, Iran
[6] Univ Tehran Med Sci, Fac Pharm, Biotechnol Res Ctr, Tehran, Iran
[7] Shahid Beheshti Univ Med Sci, Gastroenterol & Liver Dis Res Ctr, Res Inst Gastroenterol & Liver Dis, Tehran, Iran
[8] Univ Tehran Med Sci, Recombinant Vaccine Res Ctr, Tehran, Iran
[9] Univ Tehran Med Sci, Evidence Based Evaluat Cost Effectiveness & Clin, Inst Pharmaceut Sci TIPS, Tehran, Iran
[10] Shahid Beheshti Univ Med Sci, Fac Paramed Sci, Prote Res Ctr, Tehran, Iran
[11] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA
来源
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2019年 / 18卷
关键词
Probiotics; Cancer; Immune Responses; Treatment; Diabetes mellitus; Multiple sclerosis; LACTIC-ACID BACTERIA; DIET-INDUCED OBESITY; GUT-MICROBIOTA; INTESTINAL MICROBIOTA; COLORECTAL-CANCER; OXIDATIVE STRESS; BREAST-CANCER; T-CELLS; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL;
D O I
10.22037/ijpr.2020.112232.13620
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Probiotics are viable and useful microorganisms, which are beneficial factors for human and animal health by altering their microbial flora. Most of the probiotics belong to a large group of bacteria in the human gastrointestinal tract. There are several clinical shreds of evidence that show anti-carcinogenic effects of probiotics through altering digestive enzymes, inhibition of carcinogenic agents, and modulating the immune responses in experimental animals Many studies have been performed to evaluate the potential effectiveness of probiotics in treating or preventing neurological diseases such as MS and novel treatment modality for T1D. The purpose of this study is to have an overview on probiotic microorganisms and to review the previous researches on the effects of probiotics on health through currently available literatures. The study was performed using following keywords; Probiotics, Cancer, Immune system, Multiple Sclerosis (MS) and Diabetes mellitus. PubMed/Medline, Clinicaltrials.gov, Ovid, Google Scholar, and Reaxcys databases used to find the full text of related articles. According to the current available data on probiotics and related health-promoting benefits, it seems that, consumption of probiotics can lead to the prevention and reduction the risk of cancer, diabetes, and multiple sclerosis. Although for the better and more decisive conclusion, there is a need to larger sample size clinical studies with more focus on the safety of these biological agents and their possible beneficial effects on different population.
引用
收藏
页码:31 / 50
页数:20
相关论文
共 137 条
[31]   Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? [J].
Brugman, S. ;
Klatter, F. A. ;
Visser, J. T. J. ;
Wildeboer-Veloo, A. C. M. ;
Harmsen, H. J. M. ;
Rozing, J. ;
Bos, N. A. .
DIABETOLOGIA, 2006, 49 (09) :2105-2108
[32]   Probiotics and immunity: provisional role for personalized diets and disease prevention [J].
Bubnov, Rostyslav V. ;
Spivak, Mykola Ya ;
Lazarenko, Liudmyla M. ;
Bomba, Alojz ;
Boyko, Nadiya V. .
EPMA JOURNAL, 2015, 6
[33]   Microbiota regulates type 1 diabetes through Toll-like receptors [J].
Burrows, Michael P. ;
Volchkov, Pavel ;
Kobayashi, Koichi S. ;
Chervonsky, Alexander V. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (32) :9973-9977
[34]   Targeting Regulatory T Cells in the Treatment of Type 1 Diabetes Mellitus [J].
Cabrera, S. M. ;
Rigby, M. R. ;
Mirmira, R. G. .
CURRENT MOLECULAR MEDICINE, 2012, 12 (10) :1261-1272
[35]  
Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12.1519, 10.3748/wjg.v17.i12. 1519]
[36]   Q&A: insulin secretion and type 2 diabetes: why do β-cells fail? [J].
Cantley, James ;
Ashcroft, Frances M. .
BMC BIOLOGY, 2015, 13
[37]   Probiotic Lactobacilli Precautions [J].
Castro-Gonzalez, Jose M. ;
Castro, Patricia ;
Sandoval, Hilda ;
Castro-Sandoval, Diana .
FRONTIERS IN MICROBIOLOGY, 2019, 10
[38]   Microencapsulation of probiotics for gastrointestinal delivery [J].
Cook, Michael T. ;
Tzortzis, George ;
Charalampopoulos, Dimitris ;
Khutoryanskiy, Vitaliy V. .
JOURNAL OF CONTROLLED RELEASE, 2012, 162 (01) :56-67
[39]   Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour [J].
Cryan, John F. ;
Dinan, Timothy G. .
NATURE REVIEWS NEUROSCIENCE, 2012, 13 (10) :701-712
[40]   Gastrointestinal microflora, food components and colon cancer prevention [J].
Davis, Cindy D. ;
Milner, Jofm A. .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2009, 20 (10) :743-752